Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

New filovirus disease classification and nomenclature.

Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA 2nd, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM 3rd, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Pawęska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z.

Nat Rev Microbiol. 2019 May;17(5):261-263. doi: 10.1038/s41579-019-0187-4. No abstract available.

PMID:
30926957
2.

Multi-drug-resistant Enterococcus faecium bacteraemia in a liver transplant recipient.

Summers NA, Gharbin J, Friedman-Moraco R, Lyon GM, Lutgring J.

JMM Case Rep. 2018 Dec 20;6(1):e005172. doi: 10.1099/jmmcr.0.005172. eCollection 2019 Jan.

3.

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF.

Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.

4.

Transmission of Eastern Equine Encephalitis Virus from an Organ Donor to Three Transplant Recipients.

Pouch SM, Katugaha SB, Shieh WJ, Annambhotla P, Walker WL, Basavaraju SV, Jones J, Huynh T, Reagan-Steiner S, Bhatnagar J, Grimm K, Stramer SL, Gabel J, Lyon GM, Mehta AK, Kandiah P, Neujahr DC, Javidfar J, Subramanian RM, Parekh SM, Shah P, Cooper L, Psotka MA, Radcliffe R, Williams C, Zaki SR, Staples JE, Fischer M, Panella AJ, Lanciotti RS, Laven JJ, Kosoy O, Rabe IB, Gould CV; Eastern Equine Encephalitis Virus Transplant Transmission Investigation Team.

Clin Infect Dis. 2018 Oct 29. doi: 10.1093/cid/ciy923. [Epub ahead of print]

PMID:
30371754
5.

Monocular Ghost Image Offset Thresholds: Dependent on Target Size and Ghost Image Relative Brightness.

Webster AB, Lyon GM, Blowers KA, Roth GN, Deacon JA, Baan CL, Carkeet A.

Optom Vis Sci. 2018 Jul;95(7):568-574. doi: 10.1097/OPX.0000000000001243.

PMID:
29957738
6.

New Lineage of Lassa Virus, Togo, 2016.

Whitmer SLM, Strecker T, Cadar D, Dienes HP, Faber K, Patel K, Brown SM, Davis WG, Klena JD, Rollin PE, Schmidt-Chanasit J, Fichet-Calvet E, Noack B, Emmerich P, Rieger T, Wolff S, Fehling SK, Eickmann M, Mengel JP, Schultze T, Hain T, Ampofo W, Bonney K, Aryeequaye JND, Ribner B, Varkey JB, Mehta AK, Lyon GM 3rd, Kann G, De Leuw P, Schuettfort G, Stephan C, Wieland U, Fries JWU, Kochanek M, Kraft CS, Wolf T, Nichol ST, Becker S, Ströher U, Günther S.

Emerg Infect Dis. 2018 Mar;24(3):599-602. doi: 10.3201/eid2403.171905.

7.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.

Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM 3rd, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM.

Clin Infect Dis. 2018 May 17;66(11):1678-1686. doi: 10.1093/cid/cix1095.

PMID:
29438475
8.

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, Lyon GM, Vanairsdale S, Faber K, Becker S, Eickmann M, Strecker T, Brown S, Patel K, De Leuw P, Schuettfort G, Stephan C, Rabenau H, Klena JD, Rollin PE, McElroy A, Ströher U, Nichol S, Kraft CS, Wolf T; Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2017 Sep 1;65(5):855-859. doi: 10.1093/cid/cix406.

9.

Effect of positive perioperative donor and recipient respiratory bacterial cultures on early post-transplant outcomes in lung transplant recipients.

Howell CK, Paciullo CA, Lyon GM, Neujahr D, Lyu P, Cotsonis G, Hurtik M.

Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12760. Epub 2017 Oct 3.

PMID:
28803455
10.

The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, Hadley S, Herwaldt L, Kauffman C, Lyon GM, Morrison V, Patterson T, Perl T, Walker R, Hess T, Chiller T, Pappas PG; TRANSNET Investigators.

Transpl Infect Dis. 2016 Dec;18(6):921-931. doi: 10.1111/tid.12613. Epub 2016 Nov 14.

PMID:
27643395
11.

Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.

Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM 3rd, Mehta AK, Carlson RD, Hill CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Ströher U, Uyeki TM, Ribner BS, Smith JR, Yeh S.

Ophthalmology. 2016 Dec;123(12):2626-2628.e2. doi: 10.1016/j.ophtha.2016.07.013. Epub 2016 Sep 1. No abstract available.

12.

Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination.

Ellebedy AH, Jackson KJ, Kissick HT, Nakaya HI, Davis CW, Roskin KM, McElroy AK, Oshansky CM, Elbein R, Thomas S, Lyon GM, Spiropoulou CF, Mehta AK, Thomas PG, Boyd SD, Ahmed R.

Nat Immunol. 2016 Oct;17(10):1226-34. doi: 10.1038/ni.3533. Epub 2016 Aug 15.

13.

Ebola virus disease and critical illness.

Leligdowicz A, Fischer WA 2nd, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A, Hajek J, Murthy S, Ferri M, Crozier I, Ibrahima E, Lamah MC, Schieffelin JS, Brett-Major D, Bausch DG, Shindo N, Chan AK, O'Dempsey T, Mishra S, Jacobs M, Dickson S, Lyon GM 3rd, Fowler RA.

Crit Care. 2016 Jul 29;20(1):217. doi: 10.1186/s13054-016-1325-2. Review.

14.

Ebola Virus Persistence in Semen of Male Survivors.

Uyeki TM, Erickson BR, Brown S, McElroy AK, Cannon D, Gibbons A, Sealy T, Kainulainen MH, Schuh AJ, Kraft CS, Mehta AK, Lyon GM 3rd, Varkey JB, Ribner BS, Ellison RT 3rd, Carmody E, Nau GJ, Spiropoulou C, Nichol ST, Ströher U.

Clin Infect Dis. 2016 Jun 15;62(12):1552-1555. doi: 10.1093/cid/ciw202. Epub 2016 Apr 3.

PMID:
27045122
15.

Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens.

Southern TR, Racsa LD, Albariño CG, Fey PD, Hinrichs SH, Murphy CN, Herrera VL, Sambol AR, Hill CE, Ryan EL, Kraft CS, Campbell S, Sealy TK, Schuh A, Ritchie JC, Lyon GM 3rd, Mehta AK, Varkey JB, Ribner BS, Brantly KP, Ströher U, Iwen PC, Burd EM.

J Clin Microbiol. 2015 Sep;53(9):2956-60. doi: 10.1128/JCM.01317-15. Epub 2015 Jul 8.

16.

Serological Correlates of Protection against a GII.4 Norovirus.

Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, Vinjé J, Jiang X, Gregoricus N, Frenck RW, Moe CL, Chen WH, Ferreira J, Barrett J, Opekun AR, Estes MK, Borkowski A, Baehner F, Goodwin R, Edmonds A, Mendelman PM.

Clin Vaccine Immunol. 2015 Aug;22(8):923-9. doi: 10.1128/CVI.00196-15. Epub 2015 Jun 3.

17.

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.

Liddell AM, Davey RT Jr, Mehta AK, Varkey JB, Kraft CS, Tseggay GK, Badidi O, Faust AC, Brown KV, Suffredini AF, Barrett K, Wolcott MJ, Marconi VC, Lyon GM 3rd, Weinstein GL, Weinmeister K, Sutton S, Hazbun M, Albariño CG, Reed Z, Cannon D, Ströher U, Feldman M, Ribner BS, Lane HC, Fauci AS, Uyeki TM.

Ann Intern Med. 2015 Jul 21;163(2):81-90. doi: 10.7326/M15-0530.

18.

Persistence of Ebola Virus in Ocular Fluid during Convalescence.

Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, Kumar G, Smith JR, Kainulainen MH, Whitmer S, Ströher U, Uyeki TM, Ribner BS, Yeh S.

N Engl J Med. 2015 Jun 18;372(25):2423-7. doi: 10.1056/NEJMoa1500306. Epub 2015 May 7. Erratum in: N Engl J Med. 2015 Jun 18;372(25):2469.

19.

Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).

McCarty TP, Baddley JW, Walsh TJ, Alexander BD, Kontoyiannis DP, Perl TM, Walker R, Patterson TF, Schuster MG, Lyon GM, Wingard JR, Andes DR, Park BJ, Brandt ME, Pappas PG; TRANSNET Investigators.

Med Mycol. 2015 Jun;53(5):440-6. doi: 10.1093/mmy/myv018. Epub 2015 Apr 23.

PMID:
25908651
20.

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.

Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, McElroy AK, Sealy T, Campbell S, Spiropoulou C, Ströher U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS; Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2015 Aug 15;61(4):496-502. doi: 10.1093/cid/civ334. Epub 2015 Apr 22.

21.

Treatment of Ebola.

Mehta AK, Lyon GM, Varkey JB.

N Engl J Med. 2015 Apr 23;372(17):1674. doi: 10.1056/NEJMc1500452. No abstract available.

PMID:
25901439
22.

Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies.

Vora NM, Orciari LA, Niezgoda M, Selvaggi G, Stosor V, Lyon GM 3rd, Wallace RM, Gabel J, Stanek DR, Jenkins P, Shiferaw M, Yager P, Jackson F, Hanlon CA, Damon I, Blanton JD, Recuenco S, Franka R.

Transpl Infect Dis. 2015 Jun;17(3):389-95. doi: 10.1111/tid.12393. Epub 2015 May 19.

23.

Human Ebola virus infection results in substantial immune activation.

McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, Kraft CS, Lyon GM, Ribner BS, Varkey J, Sidney J, Sette A, Campbell S, Ströher U, Damon I, Nichol ST, Spiropoulou CF, Ahmed R.

Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24. doi: 10.1073/pnas.1502619112. Epub 2015 Mar 9.

24.

Radiographic imaging for patients with contagious infectious diseases: how to acquire chest radiographs of patients infected with the Ebola virus.

Auffermann WF, Kraft CS, Vanairsdale S, Lyon GM 3rd, Tridandapani S.

AJR Am J Roentgenol. 2015 Jan;204(1):44-8. doi: 10.2214/AJR.14.14041.

PMID:
25402496
25.

Successful delivery of RRT in Ebola virus disease.

Connor MJ Jr, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, Ströher U, Ribner BS, Franch HA.

J Am Soc Nephrol. 2015 Jan;26(1):31-7. doi: 10.1681/ASN.2014111057. Epub 2014 Nov 14.

26.

Clinical care of two patients with Ebola virus disease in the United States.

Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Ströher U, Uyeki TM, Ribner BS; Emory Serious Communicable Diseases Unit.

N Engl J Med. 2014 Dec 18;371(25):2402-9. doi: 10.1056/NEJMoa1409838. Epub 2014 Nov 12.

27.

Communication gaps associated with donor-derived infections.

Miller R, Covington S, Taranto S, Carrico R, Ehsan A, Friedman B, Green M, Ison MG, Kaul D, Kubak B, Lebovitz DJ, Lyon GM, Nalesnik MA, Pruett TL, Teperman L, Vasudev B, Blumberg E.

Am J Transplant. 2015 Jan;15(1):259-64. doi: 10.1111/ajt.12978. Epub 2014 Nov 6.

28.

Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan".

Wheat LJ, Nguyen MH, Alexander BD, Denning D, Caliendo AM, Lyon GM, Baden LR, Marty FM, Clancy C, Kirsch E, Noth P, Witt J, Sugrue M, Wingard JR.

J Clin Microbiol. 2014 Nov;52(11):4119. doi: 10.1128/JCM.02433-14. No abstract available.

29.

Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.

Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW Jr, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM.

J Infect Dis. 2015 Mar 15;211(6):870-8. doi: 10.1093/infdis/jiu497. Epub 2014 Sep 9.

30.

Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Sun HY, Alexander BD, Huprikar S, Forrest GN, Bruno D, Lyon GM, Wray D, Johnson LB, Sifri CD, Razonable RR, Morris MI, Stosor V, Wagener MM, Singh N.

Clin Infect Dis. 2015 Jan 1;60(1):36-44. doi: 10.1093/cid/ciu711. Epub 2014 Sep 9. Erratum in: Clin Infect Dis. 2016 Jun 15;62(12):1621.

31.

Ebola hemorrhagic fever in 2014: the tale of an evolving epidemic.

Del Rio C, Mehta AK, Lyon GM 3rd, Guarner J.

Ann Intern Med. 2014 Nov 18;161(10):746-8. doi: 10.7326/M14-1880. No abstract available.

PMID:
25133433
32.

Race and invasive fungal infection in solid organ transplant recipients.

Boehme AK, McGwin G, Andes DR, Lyon GM, Chiller T, Pappas PG, Baddley JW.

Ethn Dis. 2014 Summer;24(3):382-5.

PMID:
25065083
33.

Severity of rhinovirus infection in hospitalized adults is unrelated to genotype.

McCulloch DJ, Sears MH, Jacob JT, Lyon GM, Burd EM, Caliendo AM, Hill CE, Nix WA, Oberste MS, Kraft CS.

Am J Clin Pathol. 2014 Aug;142(2):165-72. doi: 10.1309/AJCPHIKRJC67AAZJ.

34.

Solid organ transplant donors with central nervous system infection.

Kaul DR, Covington S, Taranto S, Green M, Lyon GM, Kusne S, Miller RA, Blumberg EA.

Transplantation. 2014 Sep 27;98(6):666-70. doi: 10.1097/TP.0000000000000117.

PMID:
24914569
35.

Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.

Wheat LJ, Nguyen MH, Alexander BD, Denning D, Caliendo AM, Lyon GM, Baden LR, Marty FM, Clancy C, Kirsch E, Noth P, Witt J, Sugrue M, Wingard JR.

J Clin Microbiol. 2014 Jun;52(6):2108-11. doi: 10.1128/JCM.03500-13. Epub 2014 Apr 9.

36.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

37.

Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients.

Friedman-Moraco RJ, Mehta AK, Lyon GM, Kraft CS.

Am J Transplant. 2014 Feb;14(2):477-80. doi: 10.1111/ajt.12577. Epub 2014 Jan 16.

38.

Risk for transmission of Naegleria fowleri from solid organ transplantation.

Roy SL, Metzger R, Chen JG, Laham FR, Martin M, Kipper SW, Smith LE, Lyon GM 3rd, Haffner J, Ross JE, Rye AK, Johnson W, Bodager D, Friedman M, Walsh DJ, Collins C, Inman B, Davis BJ, Robinson T, Paddock C, Zaki SR, Kuehnert M, DaSilva A, Qvarnstrom Y, Sriram R, Visvesvara GS.

Am J Transplant. 2014 Jan;14(1):163-71. doi: 10.1111/ajt.12536. Epub 2013 Nov 26.

39.

Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis.

Singh N, Suarez JF, Avery R, Lass-Flörl C, Geltner C, Pasqualotto AC, Lyon GM, Barron M, Husain S, Wagener MM, Montoya JG.

Transpl Immunol. 2013 Dec;29(1-4):109-13. doi: 10.1016/j.trim.2013.09.007. Epub 2013 Sep 25.

PMID:
24076039
40.

Raccoon rabies virus variant transmission through solid organ transplantation.

Vora NM, Basavaraju SV, Feldman KA, Paddock CD, Orciari L, Gitterman S, Griese S, Wallace RM, Said M, Blau DM, Selvaggi G, Velasco-Villa A, Ritter J, Yager P, Kresch A, Niezgoda M, Blanton J, Stosor V, Falta EM, Lyon GM 3rd, Zembower T, Kuzmina N, Rohatgi PK, Recuenco S, Zaki S, Damon I, Franka R, Kuehnert MJ; Transplant-Associated Rabies Virus Transmission Investigation Team.

JAMA. 2013 Jul 24;310(4):398-407. doi: 10.1001/jama.2013.7986.

PMID:
23917290
41.

Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis.

Lyon GM, Abdul-Ali D, Loeffler J, White PL, Wickes B, Herrera ML, Alexander BD, Baden LR, Clancy C, Denning D, Nguyen MH, Sugrue M, Wheat LJ, Wingard JR, Donnelly JP, Barnes R, Patterson TF, Caliendo AM; AsTeC, IAAM, EAPCRI Investigators.

J Clin Microbiol. 2013 Jul;51(7):2403-5. doi: 10.1128/JCM.00744-13. Epub 2013 Apr 24.

42.

Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.

Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG.

Med Mycol. 2013 Feb;51(2):128-35. doi: 10.3109/13693786.2012.690108. Epub 2012 Jun 11.

PMID:
22680976
43.

Severity of human rhinovirus infection in immunocompromised adults is similar to that of 2009 H1N1 influenza.

Kraft CS, Jacob JT, Sears MH, Burd EM, Caliendo AM, Lyon GM.

J Clin Microbiol. 2012 Mar;50(3):1061-3. doi: 10.1128/JCM.06579-11. Epub 2012 Jan 11.

44.

Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.

Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP.

Emerg Infect Dis. 2011 Oct;17(10):1855-64. doi: 10.3201/eid1710.110087.

45.

A 35-year-old woman with prior renal transplantation admitted with a temporal brain abscess.

Kalokhe AS, Kraft CS, Lyon GM, Lim P, Wang J.

Clin Infect Dis. 2011 Oct;53(8):843-4, 797. doi: 10.1093/cid/cir545. No abstract available.

46.

Norovirus infectivity in humans and persistence in water.

Seitz SR, Leon JS, Schwab KJ, Lyon GM, Dowd M, McDaniels M, Abdulhafid G, Fernandez ML, Lindesmith LC, Baric RS, Moe CL.

Appl Environ Microbiol. 2011 Oct;77(19):6884-8. doi: 10.1128/AEM.05806-11. Epub 2011 Aug 19.

47.

A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high-risk patient populations.

Llata E, Blossom DB, Khoury HJ, Rao CY, Wannemuehler KA, Noble-Wang J, Langston AA, Ribner BS, Lyon GM, Arnold KE, Jackson DR, Brandt ME, Chiller TM, Balajee SA, Srinivasan A, Magill SS.

Diagn Microbiol Infect Dis. 2011 Sep;71(1):72-80. doi: 10.1016/j.diagmicrobio.2010.12.022.

PMID:
21851872
48.

Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities.

Lott TJ, Frade JP, Lyon GM, Iqbal N, Lockhart SR.

Med Mycol. 2012 Feb;50(2):136-42. doi: 10.3109/13693786.2011.592153. Epub 2011 Aug 15.

PMID:
21838617
49.

Randomized, double-blinded clinical trial for human norovirus inactivation in oysters by high hydrostatic pressure processing.

Leon JS, Kingsley DH, Montes JS, Richards GP, Lyon GM, Abdulhafid GM, Seitz SR, Fernandez ML, Teunis PF, Flick GJ, Moe CL.

Appl Environ Microbiol. 2011 Aug;77(15):5476-82. doi: 10.1128/AEM.02801-10. Epub 2011 Jun 24.

50.

Cytomegalovirus prostatitis in a heart transplant recipient.

Rouphael NG, Laskar SR, Smith A, Lyon GM.

Am J Transplant. 2011 Jun;11(6):1330-3. doi: 10.1111/j.1600-6143.2011.03519.x. Epub 2011 Apr 12.

Supplemental Content

Support Center